Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Lingling Li

1PUBLICATIONS

8CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 27, 2023

Efficacy and safety of anti-PD-1 monotherapy <i>versus</i> anti-PD-1 antibodies plus lenvatinib in patients with advanced hepatocellular carcinoma: a real-world experience.

Qingyan Liu, Rong Li, Lingling Li

Pageof 1

Frequent Collaborators

1 joint publications

Qingyan Liu

1 joint publications

Rong Li

1 joint publications

Gaokun Wang

1 joint publications

Shiyu Ji

1 joint publications

Xuan Zheng

1 joint publications

Xiaodong Jia

1 joint publications

Haitao Tao

1 joint publications

Yi Hu

Frequent Collaborators

1 joint publications

Qingyan Liu

1 joint publications

Rong Li

1 joint publications

Gaokun Wang

1 joint publications

Shiyu Ji

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos